CONCERT PHARMACEUTICALS INC
(206022105)
Fondsberichterstattung Bestände von CONCERT PHARMACEUTICALS INC gemäß 13F Anmeldungen
| Firmenname | Gehaltene Aktien / Nennbetrag | Marktwert | Möglichkeit | Berichtszeitraum | Gültigkeitsdatum |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 616,000 | $7,392k | Jun 30, 2019 | Aug 12, 2019 | |
| Acadian Asset Management LLC | 340,702 | $4,088k | Jun 30, 2019 | Aug 8, 2019 | |
| Panagora Asset Management Inc | 233,344 | $2,800k | Jun 30, 2019 | Aug 9, 2019 | |
| QS Investors LLC | 198,441 | $2,382k | Jun 30, 2019 | Aug 14, 2019 | |
| Tekla Capital Management LLC | 110,853 | $1,330k | Jun 30, 2019 | Aug 14, 2019 | |
| Princeton Capital Management LLC | 3,175 | $38k | Jun 30, 2019 | Aug 12, 2019 | |
| PURA VIDA Investments LLC | 2,249 | $17k | Call | Jun 30, 2019 | Aug 14, 2019 |
| Prelude Capital Management LLC | 804 | $10k | Jun 30, 2019 | Aug 14, 2019 |